![SciELO - Brasil - Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers Levels of CEA and Ca 19 - SciELO - Brasil - Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers Levels of CEA and Ca 19 -](https://minio.scielo.br/documentstore/1678-2674/Yx8VdWjPFJ3nHRLDhR7XZZC/847e776819859cf9280b81a9166bbd47d0a8608d.jpg)
SciELO - Brasil - Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers Levels of CEA and Ca 19 -
![Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen](https://www.intechopen.com/media/chapter/46036/media/fig1.png)
Role of Tumour Markers in Diagnosis and Follow up of Colorectal Cancer — Potential for Future Research | IntechOpen
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr1.jpg)